These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6299409)

  • 1. Naloxone and self-mutilation.
    Richardson JS; Zaleski WA
    Biol Psychiatry; 1983 Jan; 18(1):99-101. PubMed ID: 6299409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of naloxone on self-injurious behavior: a case study.
    Davidson PW; Kleene BM; Carroll M; Rockowitz RJ
    Appl Res Ment Retard; 1983; 4(1):1-4. PubMed ID: 6307142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbamazepine trial for Lesch-Nyhan self-mutilation.
    Roach ES; Delgado M; Anderson L; Iannaccone ST; Burns DK
    J Child Neurol; 1996 Nov; 11(6):476-8. PubMed ID: 9120227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naloxone attenuates self-abusive behavior in developmentally disabled clients.
    Sandman CA; Datta PC; Barron J; Hoehler FK; Williams C; Swanson JM
    Appl Res Ment Retard; 1983; 4(1):5-11. PubMed ID: 6870234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-mutilation and sleep stage in the Lesch-Nyhan syndrome.
    Mizuno T; Ohta R; Kodama K; Kitazumi E; Minejima N; Takeishi M; Segawa M
    Brain Dev; 1979; 1(2):121-5. PubMed ID: 233225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of narcotic antagonists on self-injurious behavior: a single case study.
    Bernstein GA; Hughes JR; Mitchell JE; Thompson T
    J Am Acad Child Adolesc Psychiatry; 1987 Nov; 26(6):886-9. PubMed ID: 3429408
    [No Abstract]   [Full Text] [Related]  

  • 7. Failure of naloxone to reduce self-injurious behavior in two developmentally disabled females.
    Beckwith BE; Couk DI; Schumacher K
    Appl Res Ment Retard; 1986; 7(2):183-8. PubMed ID: 3729382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin as a novel treatment for self-mutilation in Lesch-Nyhan syndrome.
    Dabrowski E; Smathers SA; Ralstrom CS; Nigro MA; Leleszi JP
    Dev Med Child Neurol; 2005 Sep; 47(9):636-9. PubMed ID: 16138673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of naloxone on brain and behavior of a self-injurious woman.
    Sandman CA; Barron JL; Crinella FM; Donnelly JF
    Biol Psychiatry; 1987 Jul; 22(7):899-906. PubMed ID: 3607117
    [No Abstract]   [Full Text] [Related]  

  • 10. Naloxone abolishes self-injuring in a mentally retarded child.
    Sandyk R
    Ann Neurol; 1985 May; 17(5):520. PubMed ID: 4004178
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of risperidone on the self-mutilation of Lesch-Nyhan syndrome].
    Saito Y; Yamashita S; Kaneko K; Kimura S; Osawa M
    No To Hattatsu; 2001 May; 33(3):281-2. PubMed ID: 11391974
    [No Abstract]   [Full Text] [Related]  

  • 12. Botulinum toxin: treatment of self-mutilation in patients with Lesch-Nyhan syndrome.
    Gutierrez C; Pellene A; Micheli F
    Clin Neuropharmacol; 2008; 31(3):180-3. PubMed ID: 18520986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of L-5-hydroxytryptophan on self-mutilatin in Lesch-Nyhan disease: a negative report.
    Anderson LT; Herrmann L; Dancis J
    Neuropadiatrie; 1976 Nov; 7(4):439-42. PubMed ID: 1087383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: Self mutilation in Lesch-Nyhan syndrome.
    Mizuno TI; Yugari Y
    Lancet; 1974 Apr; 1(7860):761. PubMed ID: 4132504
    [No Abstract]   [Full Text] [Related]  

  • 15. Naltrexone attenuates self-injurious behavior in mentally retarded subjects.
    Kars H; Broekema W; Glaudemans-van Gelderen I; Verhoeven WM; van Ree JM
    Biol Psychiatry; 1990 Apr; 27(7):741-6. PubMed ID: 2158355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-mutilation in Lesch-Nyhan disease is caused by dopaminergic denervation.
    Goldstein M; Anderson LT; Reuben R; Dancis J
    Lancet; 1985 Feb; 1(8424):338-9. PubMed ID: 2857386
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of opioid receptors in self-aggression in rats.
    Sharma R; Manchanda SK; Nayar U
    Indian J Physiol Pharmacol; 1991 Jul; 35(3):165-9. PubMed ID: 1665147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare variant of Lesch-Nyhan syndrome without self-mutilation or nephrolithiasis.
    Kersnik Levart T
    Pediatr Nephrol; 2007 Nov; 22(11):1975-8. PubMed ID: 17680274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of risperidone in the neonatal 6-hydroxydopamine model of Lesch-Nyhan syndrome.
    Allen SM; Freeman JN; Davis WM
    Pharmacol Biochem Behav; 1998 Feb; 59(2):327-30. PubMed ID: 9476977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug therapy for self mutilators. Remarks and prospects].
    Basquin M
    Neuropsychiatr Enfance Adolesc; 1984 Apr; 32(4):209-12. PubMed ID: 6146943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.